Surgical treatment strategies for invasive thymoma
- PMID: 33447453
- PMCID: PMC7797825
- DOI: 10.21037/jtd-19-3045
Surgical treatment strategies for invasive thymoma
Abstract
A thymoma is a common anterior thymus mediastinal tumor composed of atypical epithelial tumor cells, though the morbidity rate is lower as compared to other types of thoracic malignancy such as lung cancer and lung metastasis from another primary cancer. As a result, clinical data regarding thymomas have not been well discussed as compared to those of other carcinomas. Also, because of the low morbidity rate and insufficient clinical experience, oncological characteristics and clinical treatment options are poorly understood. Surgical complete resection is the most reliable option for clinical treatment of a thymoma. This tumor can easily develop adjacent to several different structures and nearby organs, such as the pericardium, lungs, and great vessels, which are easily invaded when the size is large, and a combined resection is then needed. When en bloc resection is considered to be difficult based on evaluation with preoperative modalities, induction chemotherapy followed by surgery is recommended. Moreover, when pleural dissemination is revealed during pre- or peri-operative procedures, volume reduction surgery has been reported by several groups to extend prognosis. On the other hand, in cases with a small-sized tumor, a minimally invasive surgical procedure, such as video-assisted thoracic surgery (VATS) or robotic-assisted thoracic surgery (RATS), is usually selected. Because of the wide variety of cases with thymoma, a deliberate strategy and skillful techniques are necessary for effectual surgical treatment. In this review, we discuss strategies that have been shown to be effective for treating patients with early and advanced thymoma, including those with involved adjacent organs.
Keywords: Surgical approach; advanced thymoma; en bloc resection.
2020 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at: http://dx.doi.org/10.21037/jtd-19-3045). The series “Thymoma” was commissioned by the editorial office without any funding or sponsorship. YS serves as an unpaid editorial board member of Journal of Thoracic Disease from Sept 2019 to Aug 2021. The other authors have no other conflicts of interest to declare.
References
-
- Korst RJ, Fernando S, Catlin AC, et al. Contributors to the International Thymic Malignancy Interest Group (ITMIG) Prospective Database. Positron Emission Tomography in Thymic Tumors: Analysis Using a Prospective Research Database. Ann Thorac Surg 2017;104:1815-20. 10.1016/j.athoracsur.2017.06.053 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials